# Efficacy of Topical Cannabidiol for Eczema

> **NCT06994520** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Khon Kaen University** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Pruritus
- Eczema
- Nummular Eczema
- Atopic Dermatitis
- Prurigo Nodularis

## Interventions

- **OTHER:** Cannabidiol (CBD)
- **DRUG:** Triamcinolone (TAC) 0.1% cream

## Key facts

- **NCT ID:** NCT06994520
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994520, "Efficacy of Topical Cannabidiol for Eczema". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06994520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*